September 2017

Exicure Expansion

Exicure is a clinical stage biotechnology company developing a new class of immunomodulatory and gene silencing drugs against validated targets. The 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of nucleic acid therapeutics in multiple organs. Lead programs address diseases from inflammatory disorders to oncology. SNA™ technology originated in the lab of Professor Chad A.